6 questions investors should ask when evaluating psychedelic biotech companies
TechCrunch
APRIL 6, 2022
He co-hosts Business Trip, a podcast about psychedelic entrepreneurship. As a venture firm that invests in psychedelics, we receive hundreds of pitches every month from founders developing psychedelic therapeutics. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. Greg Kubin.
Let's personalize your content